全文获取类型
收费全文 | 2837篇 |
免费 | 401篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 78篇 |
妇产科学 | 58篇 |
基础医学 | 20篇 |
口腔科学 | 6篇 |
临床医学 | 855篇 |
内科学 | 985篇 |
皮肤病学 | 172篇 |
神经病学 | 399篇 |
特种医学 | 74篇 |
外科学 | 349篇 |
综合类 | 2篇 |
预防医学 | 101篇 |
眼科学 | 42篇 |
药学 | 12篇 |
肿瘤学 | 95篇 |
出版年
2023年 | 68篇 |
2021年 | 44篇 |
2020年 | 67篇 |
2019年 | 18篇 |
2018年 | 82篇 |
2017年 | 102篇 |
2016年 | 102篇 |
2015年 | 115篇 |
2014年 | 150篇 |
2013年 | 178篇 |
2012年 | 60篇 |
2011年 | 79篇 |
2010年 | 155篇 |
2009年 | 224篇 |
2008年 | 102篇 |
2007年 | 30篇 |
2006年 | 65篇 |
2005年 | 24篇 |
2004年 | 16篇 |
2003年 | 24篇 |
2002年 | 29篇 |
2001年 | 65篇 |
2000年 | 28篇 |
1999年 | 54篇 |
1998年 | 65篇 |
1997年 | 122篇 |
1996年 | 109篇 |
1995年 | 101篇 |
1994年 | 85篇 |
1993年 | 82篇 |
1992年 | 71篇 |
1991年 | 38篇 |
1990年 | 28篇 |
1989年 | 36篇 |
1988年 | 41篇 |
1987年 | 33篇 |
1986年 | 30篇 |
1985年 | 32篇 |
1984年 | 31篇 |
1983年 | 29篇 |
1982年 | 31篇 |
1981年 | 16篇 |
1980年 | 36篇 |
1978年 | 19篇 |
1974年 | 17篇 |
1973年 | 20篇 |
1960年 | 21篇 |
1956年 | 16篇 |
1955年 | 20篇 |
1954年 | 19篇 |
排序方式: 共有3257条查询结果,搜索用时 0 毫秒
1.
Femoral access‐related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure 下载免费PDF全文
2.
M Vijaya Lakshmi MRCP G V Sridharan MRCP D Butterworth MRCP 《International journal of clinical practice》1993,47(3):164-165
Gallstones are common and their incidence increases with age.1 Fifty per cent of these stones are in the common bile duct (CBD) in the elderly.2 Most of them are silent but with time there is an increasing chance of developing symptoms which are more likely to be serious in the elderly.3 Failure to relieve mechanical obstruction of bile flow may lead to secondary biliary cirrhosis.4 It has been estimated that on average secondary biliary cirrhosis develops some seven years after the onset of obstruction from a stricture, four and half years after gallstone obstruction and 10 months after the onset of malignant stricture.5 The characteristic features are the pathological findings of portal-portal linkages, with a pattern of monolobular cirrhosis and the preservation of normal vascular relationships.6 Secondary biliary cirrhosis may lead to hepatic insufficiency and portal hypertension with the resultant complications, such as bleeding oesophageal varices, hypersplenism with pancytopenia, ascites and encephalopathy. We describe a patient in whom the diagnosis was not suspected until laparotomy and confirmed only at autopsy. 相似文献
3.
Over recent years the pharmacological treatment strategy for rheumatoid arthritis (RA) has changed. An early, aggressive approach has been adopted with a view to maintaining functional capacity. The changing role of nonsteroidal antiinflammatory agents is discussed in the light of the potential toxicity of this class of drugs. The current use of second-line agents is dealt with in depth and includes guidelines to patient monitoring. Particular attention has been paid to the growing use of cyclosporin A in the treatment of RA as this drug represents the newest, most potent, nonexperimental form of treatment. The questions of when to introduce second-line agents, who should receive treatment and how many drugs should be prescribed are all addressed in this review. The relative efficacy and toxicity of these agents is discussed and a treatment protocol is proposed. 相似文献
4.
5.
Tsungai Chipato MRCOG David L. Healy PhD FRACOG Beverley Vollenhoven MRACOG Helen M. Buckler MRCP 《The Australian & New Zealand journal of obstetrics & gynaecology》1991,31(4):383-384
We present these 3 cases to alert others to the possibility of severe pain with rapid shrinkage of fibroids occurring during LHRH analogue treatment. We suggest management of such events should not be surgical except for vaginal excision of prolapsed fibroid polyps. 相似文献
6.
Edward H.C. Wong MRCP Thomas W.H. Leung MRCP K.S. Lawrence Wong FRCP 《Journal of neuroimaging》2007,17(1):87-88
We report a 33-year-old man with seronegative arthritis who had an acute infarct at the left lentiform nucleus while taking etoricoxib and thalidomide regularly. Extensive investigations did not find any evidence of large artery atherosclerosis, vasculitis, cardioembolic source or anti-phospholipid antibodies. While it is possible that a short smoking history, hyperlipidemia, and the use of thalidomide could have contributed to the thrombosis of a small penetrator vessel, we postulated that the prolonged use of etoricoxib is another possible contributing factor. 相似文献
7.
Dr. Y. F. Mangnall PhD D. D. Kerrigan FRCS A. G. Johnson MChir N. W. Read MRCP 《Digestive diseases and sciences》1991,36(12):1680-1684
Applied potential tomography (APT) is a new noninvasive, nonradioactive method of measuring gastric emptying, which generates profiles of emptying of liquids that are similar to those obtained simultaneously by scintigraphy and dye dilution. This study validates the ability of APT to measure emptying of a solid beefburger test meal from the stomach by comparing the results obtained with those obtained simultaneously by scintigraphy. When acid secretion was inhibited, there was a significant correlation between the two methods for the time taken for half the meal to empty from the stomach and the amount of meal emptied at different time intervals. Furthermore, the profiles of gastric emptying obtained by APT resembled those obtained by scintigraphy in most studies. If acid secretion was not inhibited, there was no correlation between values obtained by the two methods. 相似文献
8.
Emma J. Birks MRCP Magdi H. Yacoub DSc FRS Ani Anyanwu FRCS Rosemary Radley Smith FRCP Nicholas R. Banner FRCP Asghar Khaghani FRCS 《The Journal of heart and lung transplantation》2004,23(12):3688-1344
BACKGROUND: Transplantation for patients with a high pulmonary vascular resistance (PVR) carries an increased risk of mortality and right heart failure following heart transplantation and continues to be a major problem. We evaluated the use of hearts from patients who underwent heart and lung transplantation for primary pulmonary hypertension (PPH) as part of a domino procedure because these hearts have hypertrophied right ventricles used to increased pulmonary pressures, but could have a compromised left ventricle or irreversible damage of the right ventricle. METHODS: We reviewed 12 patients with PVR >4 Wood units who underwent orthotopic heart transplantation between 1989 and 1998 using hearts from donors with PPH as part of a domino procedure. RESULTS: We studied 10 men and 2 women, mean age 42.9 years. Mean PVR was 5.3 (range, 4-9) Wood units. Mean ischemia time was 85.3 minutes, and mean donor age was 32 years. Actuarial survival was 75% at 1 year and 75% at 5 years. In the early post-operative period, 3 patients had temporary arrhythmias, 2 required permanent pacemaker implantation, 1 had atrial fibrillation, and 1 had ventricular tachycardia that required defibrillator implantation. At a mean follow-up of 7.8 years, 2 patients had developed asymptomatic transplant coronary disease (both at 8.5 years after transplantation), 1 moderate and 1 very mild; the rest had none. Mean left ventricular ejection fraction at latest follow-up was 70.1% (range, 63%-78%). Right ventricular function assessed clinically and by echocardiography was adequate in the short and long term. CONCLUSIONS: Our results suggest that heart and lung recipients with PPH can provide useful donor hearts to patients with increased PVR and that these hearts function well in the intermediate and long term. 相似文献
9.
From mid-October 1989 to mid-July 1990 all newly admitted residents to Bury Local Authority Residential Homes were comprehensively medically screened. In a series of 100 residents eight had early Parkinson's disease (six of them hitherto undiagnosed). Seven showed evidence of Vitamin C deficiency. Of the seven showing evidence of deficiency, four suffered from early Parkinson's disease. Of the 93 without evidence of Vitamin C deficiency only four had Parkinson's disease. This indicates a significantly higher prevalence of Parkinson's disease in the group with Vitamin C deficiency (P less than 0.001 using Fisher's exact). 相似文献
10.
P Emery MD FRCP R Luqmani MD MRCP C Gordon MA MRCP 《International journal of clinical practice》1994,48(2):82-86
SUMMARY Disease-modifying antirheumatic drugs are used in virtually all patients with established rheumatoid arthritis. An increasingly large number of new drugs is now available. Furthermore, old therapies are being used in novel ways. Treatment is now begun earlier and patients are rarely left untreated. This report summarises recent developments regarding the drugs currently in use and those that may be available in the near future. 相似文献